148 related articles for article (PubMed ID: 17582184)
1. Hepatitis A vaccination in chronic liver disease: is it really required in a tropical country like India?
Joshi N; Rao S; Kumar A; Patil S; Rani S
Indian J Med Microbiol; 2007 Apr; 25(2):137-9. PubMed ID: 17582184
[TBL] [Abstract][Full Text] [Related]
2. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
Anand AC; Nagpal AK; Seth AK; Dhot PS
J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
[TBL] [Abstract][Full Text] [Related]
3. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver?
Duseja A; Sharma S; Das K; Dhiman RK; Chawla YK
Trop Gastroenterol; 2004; 25(4):162-3. PubMed ID: 15912973
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy.
John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P
J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469
[TBL] [Abstract][Full Text] [Related]
6. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination.
Acharya SK; Batra Y; Bhatkal B; Ojha B; Kaur K; Hazari S; Saraya A; Panda SK
J Gastroenterol Hepatol; 2003 Jul; 18(7):822-7. PubMed ID: 12795755
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of hepatitis A virus antibody in patients with chronic liver disease--experience from a tertiary care hospital in north India.
Dhotial A; Kapoor D; Kumar N
Trop Gastroenterol; 2002; 23(4):170-1. PubMed ID: 12833702
[TBL] [Abstract][Full Text] [Related]
8. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey.
Batra Y; Bhatkal B; Ojha B; Kaur K; Saraya A; Panda SK; Acharya SK
Bull World Health Organ; 2002; 80(9):728-31. PubMed ID: 12378291
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
11. Anti-hepatitis A seroprevalence among chronic viral hepatitis patients in Kelantan, Malaysia.
Ahmad F; Hamzah NA; Mustaffa N; Gan SH
World J Gastroenterol; 2011 Sep; 17(36):4130-4. PubMed ID: 22039329
[TBL] [Abstract][Full Text] [Related]
12. Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea.
Kim DY; Ahn SH; Lee HW; Kim SU; Kim JK; Paik YH; Lee KS; Han KH; Chon CY
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):923-6. PubMed ID: 18049159
[TBL] [Abstract][Full Text] [Related]
13. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
Al-Aziz AM; Awad MA
East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
[TBL] [Abstract][Full Text] [Related]
15. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
[TBL] [Abstract][Full Text] [Related]
17. Is hepatitis A vaccination necessary in Indian patients with cirrhosis of liver?
Xavier S; Anish K
Indian J Gastroenterol; 2003; 22(2):54-5. PubMed ID: 12696823
[TBL] [Abstract][Full Text] [Related]
18. Serological study of hepatitis A virus infection amongst the students of a medical college in Delhi & evaluation of the need of vaccination.
Jindal M; Rana SS; Gupta RK; Das K; Kar P
Indian J Med Res; 2002 Jan; 115():1-4. PubMed ID: 12424929
[TBL] [Abstract][Full Text] [Related]
19. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
20. Age-stratified anti-HAV positivity in Pune, India after two decades: Has voluntary vaccination impacted overall exposure to HAV?
Arankalle V; Tiraki D; Kulkarni R; Palkar S; Malshe N; Lalwani S; Mishra A
J Viral Hepat; 2019 Jun; 26(6):757-760. PubMed ID: 30739364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
